United States
Premiumsupplier
Pasireotide pamoate CAS NO.396091-79-5
- Min.Order: 0
- Payment Terms:
- Product Details
Keywords
- Pasireotide embonate
- SOM230 pamoate
Quick Details
- ProName: Pasireotide pamoate
- CasNo: 396091-79-5
- Molecular Formula: C81H82N10O15
- Application: For research use only.
- Purity: 95%
- LimitNum: 0
Superiority
We provide customized and high-quality Pasireotide pamoate product for your project.
Details
Pasireotide, also known as SOM230, is an orphan drug approved for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs.
